Stay updated on TAK-659 in AML Clinical Trial

Sign up to get notified when there's something new on the TAK-659 in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAK-659 in AML Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added 'Acute myeloid leukemia' as a topic tag and included a new Resources link to the Genetic and Rare Diseases Information Center for AML information.
    Difference
    0.1%
    Check dated 2026-04-02T15:32:00.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Website revision updated from v3.4.3 to v3.5.0. No changes to the trial content or page functionality are introduced.
    Difference
    0.0%
    Check dated 2026-03-19T04:53:05.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T02:16:14.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The study locations list was updated, with new sites added and some existing sites removed. This alters where potential participants can enroll in the trial.
    Difference
    0.0%
    Check dated 2026-03-04T23:54:54.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added revision tag v3.4.2 and removed the previous v3.4.1 notice; these are minor updates that do not alter trial details.
    Difference
    0.3%
    Check dated 2026-02-11T11:42:53.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with links to cc.nih.gov and opm.gov, and updated the site revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-04T10:26:03.000Z thumbnail image

Stay in the know with updates to TAK-659 in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAK-659 in AML Clinical Trial page.